Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
May 2019
Historique:
received: 15 10 2018
revised: 07 02 2019
accepted: 07 02 2019
pubmed: 12 2 2019
medline: 16 11 2019
entrez: 12 2 2019
Statut: ppublish

Résumé

The endoplasmic reticulum aminopeptidase protein 1 gene (ERAP1) is related to several human diseases, including Behçet syndrome (BS), a multisystemic disorder with unknown etiology. ERAP1 is involved in immune response and its role can be influenced by gene single nucleotide variations (SNVs). We genotyped the ERAP1 whole structure in 50 consecutive BS patients and 50 ethnically-matched healthy controls using both bioinformatics and molecular methodologies. We identified two novel heterozygous missense SNVs of ERAP1 exon3 responsible for the p.Glu183Val and p.Phe199Ser changes. The first variation was recognized in 7/50 (14%) BS patients and involved the substrate binding site (p.Glu183) required for the anchorage of the peptide N-terminal group. The SNV was predicted to be a damaging variation, as well as the p.Phe199Ser substitution (PolyPhen-2 and SIFT on line software). 3D protein structure prediction showed a change in energy score when the wild-type and the variant states were compared, probably influencing the substrate binding and the protein folding. The first variation was associated to a more stable protein chain, while the second polymorphism was related to a less stable protein chain. Our data need to be tested in larger genetic studies.

Identifiants

pubmed: 30742879
pii: S0198-8859(18)30941-8
doi: 10.1016/j.humimm.2019.02.003
pii:
doi:

Substances chimiques

Minor Histocompatibility Antigens 0
Aminopeptidases EC 3.4.11.-
ERAP1 protein, human EC 3.4.11.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-338

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Maria Carmela Padula (MC)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy; Department of Science, University of Basilicata, viale dell'Ateneo Lucano, Potenza 85100, Italy. Electronic address: mcpadula25@gmail.com.

Pietro Leccese (P)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy. Electronic address: pietroleccese1979@gmail.com.

Nancy Lascaro (N)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy. Electronic address: nancylascaro@libero.it.

Teresa Carbone (T)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy. Electronic address: carbone_teresa@libero.it.

Michele Gilio (M)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy.

Angela Anna Padula (AA)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy. Electronic address: angela.padula@ospedalesancarlo.it.

Giuseppe Martelli (G)

Department of Science, University of Basilicata, viale dell'Ateneo Lucano, Potenza 85100, Italy. Electronic address: giuseppe.martelli@unibas.it.

Salvatore D'Angelo (S)

Rheumatology Institute of Lucania (IReL) and Rheumatology Department of Lucania, San Carlo Hospital of Potenza, via Potito Petrone, Potenza 85100, Italy; Basilicata Ricerca Biomedica (BRB) Foundation, Matera 75100, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH